Molecular Neurodegeneration
Impact Factor Trend (2018–2026)
Clarivate IF trend for Molecular Neurodegeneration
SCImago Journal Rank citation prestige weighting
139 papers with at least that number of citations each
Aims & Scope
Molecular Neurodegeneration is an open access, peer-reviewed journal that encompasses all aspects of neurodegeneration research at the molecular and cellular levels. Neurodegenerative diseases collectively refer to neurological disorders that result from neurodegeneration and include, but are not limited to, Alzheimer's disease, Parkinson's disease, Huntington's disease, and prion diseases. These diseases, which are often associated with advanced aging and display varying degrees of dementia, have become a significant public health issue as humans live longer and the aging population grows larger. Recent advances in the molecular and cellular mechanisms underlying the pathogenesis of these neurodegenerative disorders have allowed for a better understanding of the disease mechanisms.
Special Issues
Calls for PapersNo active Calls for Papers found for this journal.
WoS Categories & Quartiles
Detailed JCR / JCI category rankings and quartile breakdown from Clarivate
NEUROSCIENCES
NEUROSCIENCES
Annual Historical Statistics & Publications
Track annual publication volume, total citations, and Impact Factor evolution
SCImago & Scopus Journal Intelligence
Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact
Weighted prestige citation metric per document indexed in the Scopus database.
Average citations received per document published in the 2-year window.
Estimated Article Processing Charge for Open Access publication.
Scopus 3-Year Publication & Citation Window
Aggregated from Scopus database across the 3-year SJR evaluation window.
Societal Impact & Inclusivity (SCImago)
Citations in government and international policy documents
Percentage of female authors published in the journal
Real-world societal policy reach and author gender diversity tracked by SCImago.
Scopus Subject Categories
Journal Metrics & Citation Visualizations
Total Cites vs Self-Cites
Evaluation of scholarly independence and citation reach
Citations per Document
Citation metric windows across 2, 3, and 4 years
Chinese Academy of Sciences (CAS) Classification
Major / minor zone classification and CAS Early Warning List history
Academic Intelligence Overview & Context
ImpaQ AnalysisMolecular Neurodegeneration (acronym: mond, abbr: MOL. NEURODEGENER, ISSN: 1750-1326) is a peer-reviewed international scholarly journal in the field of Medicine, published by BioMed Central in England since 2006. The periodical holds a Journal Impact Factor (JIF) of 19.6, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 6.262 (Q1), an H-index of 139.
The journal enforces rigorous peer evaluation with a publication frequency of Monthly, an annual output of approximately 76 scientific articles. In terms of accessibility and author fees, it operates under the Gold OA model with an estimated APC of $4,539 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.
Publishing & Editorial Information
Detailed publisher, peer-review turnaround, and publication cycle specifications
Similar Journals in Discipline
Journals in the same research field with comparable impact metrics